These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31382299)

  • 1. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.
    Nath S; Reynolds AM; Lakshminrusimha S; Ma C; Hudak ML; Ryan RM
    Am J Perinatol; 2020 Dec; 37(14):1425-1431. PubMed ID: 31382299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL; Mettelman BB; Bode MM; Gross SJ
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Postnatal Steroids.
    Halliday HL
    Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
    Ryan RM; Keller RL; Poindexter BB; D'Angio CT; Shaw PA; Bellamy SL; Moore PE; McPherson C; Greenberg JM;
    J Pediatr; 2019 May; 208():148-155.e3. PubMed ID: 30857774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001145. PubMed ID: 19160189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001146. PubMed ID: 19160190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Severity Score with Regard to Birthweight during the Early Days of Life for Predicting Pulmonary Hypertension in Preterm Infants.
    Seo YM; Yum SK; Sung IK
    J Trop Pediatr; 2020 Dec; 66(6):561-568. PubMed ID: 32240314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2012 May; (5):CD002057. PubMed ID: 22592682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.